Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy

Hypertension

Volumn 34, Issue 3, 1999, Pages 408-414

  Cao, Zemin ^a   Dean, Rachael ^a   Wu, Leonard ^a   Casley, David ^a   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Proliferating cell nuclear antigen; Receptors, angiotensin; Vascular proliferation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; CELL NUCLEUS ANTIGEN; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CAPILLARY PROLIFERATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

EID: 0032886025     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.408     Document Type: Article

References (35)

1. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999;33: 613-621.
2. Stall M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
3. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.
4. Tsuzuki S, Eguchi S, Inagami T. Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem Biophys Res Commun. 1996; 228:825-830.
5. Ozawa Y, Suzuki Y, Murakami K, Miyazaki H. The angiotensin II type 2 receptor primarily inhibits cell growth via pertussis toxin-sensitive G proteins. Biochem Biophys Res Commun. 1996;228:328-333.
6. Saward L, Zahradka P. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol. 1996;28:499-506.
7. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992;20:737-745.
8. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92: 10663-10667.
9. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996;98:418-425.
10. Li JS, Touyz RM, Schiffrin EL. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension. 1998; 31:487-492.
11. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17: 626-635.
12. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int. 1997;51:1553-1567.
13. Cao Z, Hulthén UL, Allen T, Cooper ME. Angiotensin converting enzyme inhibition and calcium channel blockade attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independent of their hypotensive action. J Hypertens. 1998;16:793-799.
14. Macari D, Bottari S, Whitebread S, De Gasparo M, Levens N. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol. 1993;249: 85-93.
15. Buñag RD. Validation in awake rat of a tail-cuff method for measurement of systolic blood pressure. J Appl Physiol. 1973;34:279-282.
16. Mendelsohn F, Hutchinson J, Johnston CI. A review of plasma renin measurements and their clinical significance. Aust NZ J Med. 1971;1: 86-93.
17. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jems G, Gilbet R. Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. J Clin Invest. 1997;99:1016-1027.
18. Mendelsohn FA, Millan M, Quirion R, Aguilera G, Chou ST, Catt KJ. Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography. Kidney Int Suppl. 1987;20:S40-S44.
19. Kato H, Hou J, Chobanian AV, Brecher P. Effect of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension. 1996;28:153-158.
20. Brilla CG, Zhou G, Matsubara L, Weber KL. Collagen metabolism in cultured adult rat cardiac fibroblast: response to angiotensin II and aldosterone. J. Mol. Cell Cardiol. 1994;26:809-820.
21. Lorenzo O, Ruiz-Ortega M, Ortego J. Role of AT1 and AT2 receptors in angiotensin II-induced nuclear transcription factor-Κ B activation in cultured cells. J Hypertens. 1998;16:S26. Abstract.
22. Munzenmaier DH, Greene AS. Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am J Physiol. 1995;269:H565-H570.
23. Kunert Radek J, Stepien H, Komorowski J, Pawlikowski M. Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors. Biochem Biophys Res Commun. 1994;198:1034-1039.
24. Macari D, Whitebread S, Cumin F, De Gasparo M, Levens N. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol. 1994;259:27-36.
25. Champion HC, Garrison EA, Estrada LS, Potter JM, Kadowitz PJ. Analysis of responses to angiotensin I and angiotensin I-(3-10) in the mesenteric vascular bed of the cat. Eur J Pharmacol. 1996;309:251-259.
26. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-51.
27. Lever AF. Slow developing pressor effect of angiotensin II and vascular structure. J Hypertens Suppl. 1993;11:S27-28.
28. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension. 1998;32:467-472.
29. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;71:1482-1489.
30. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang SS. Distribution and function of cardiac angiotensin AT1-and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994;267:H844-H852.
31. Wu J, Edwards D, Berecek KH. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1994;23:819-822.
32. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes. 1994;43:1180-1184.
33. Smits JF, Passier RC, Nelissen Vrancken HJ, Cleutjens JP, Kuizinga MC, Daemen MJ. Does ACE inhibition limit structural changes in the heart following myocardial infarction? Eur Heart J. 1995;16 (suppl):46-51.
34. Wiemer G, Scholkens BA, Wagner A, Heitsch H, Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens Suppl. 1993;11: S234-S235.
35. Cheng HF, Becker BN, Burns KD, Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1995;95:2012-2019.